On August 4, 2023, the Extraordinary Shareholders’ Meeting of the Company issued 1 to 2,592,593 series D shares. The final number of series D shares acquired amounted to 1,851,852 shares, as a result of which the Company’s share capital was increased to the current sum of: PLN 2,065,653.70. The share capital increase and the new consolidated text of the Company’s Articles of Association were registered in the Register of Entrepreneurs of the National Court Register on December 27, 2023.
4Cell Therapies -